Lixisenatide, which stimulates insulin release when glucose levels become too high, and slows down stomach emptying will be sold under the brand name Lyxumia soon. Related terms:lyxumia launch datelyxumialyxumia pronunciationlyxumia approvallyxumia ppthow safe is lyxumialyxumia experienceslyxumia launchwww allaboutdiabetes net lyxumia-will-be-available-soonwww permanent cure of diabetiespronounce lyxumialixisenatide powerpointlixisenatide pronounciationlixisenatide pronunciationlixisenatide power point presentationlyxumia 2012acceptability and nutrients chicharon […]

Lixisenatide (Lyxumia) is an injectable drug for diabetes that acts as a GLP-1 receptor agonist for controlling blood sugar. It was discovered by the Zealand Pharma A/S in Denmark and licensed and developed by Sanofi Pharmaceuticals. GLP-1 is a natural peptide that is released in blood after eating meal and helps in suppressing the secretion […]